BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:Mini-Symposium for Machine Learning in Chemistry
DTSTART:20260512T151500
DTEND:20260512T170000
DTSTAMP:20260513T001316Z
UID:138a2074e8b179d8e40191af8a441fd3b973d34bcddca13e78517bdd
CATEGORIES:Conferences - Seminars
DESCRIPTION:Lucia Morán\, Paula Torren Peraire\nThe ML Seminars Series is
  hosting a mini-symposium to celebrate the end of the semester! Join us fo
 r excellent talks on data-driven approaches in transition metal catalysis 
 and drug discovery. \n\nLucia Moran\nData-Driven Approaches to Transition
 -Metal Catalysis\nThe application of machine learning to homogeneous catal
 ysis is transforming the field\, with computational methods addressing key
  challenges in catalyst design\, mechanistic understanding\, and reaction 
 optimization. In this talk\, I will present recent work on how the combina
 tion of data-driven approaches and quantum chemistry can improve the model
 ling and discovery of transition-metal (TM) catalysts.\nI will first outli
 ne the current landscape of AI in homogeneous catalysis\, focusing on rece
 nt advances in chemical representations and computational workflows. I wil
 l then present our recent developments in TM descriptors\, highlighting th
 eir transferability across different chemical motifs. Finally\, I will sho
 wcase the application of these methods to the discovery of bifunctional ca
 talysts for CO₂ hydrogenation to methanol. By combining high-throughput 
 virtual screening with machine learning surrogate models\, we explore larg
 e chemical spaces to identify and prioritize candidates for experimental v
 alidation.\n\nBiography\nLucía Morán is a computational chemist working 
 at the interface of homogeneous catalysis and machine learning. She obtain
 ed her MSc and PhD at the Institute of Chemical Research of Catalonia unde
 r the supervision of Prof. Feliu Maseras\, where her research focused on o
 rganometallic reaction mechanisms and the development of data-driven chemi
 cal descriptors. During her doctoral studies\, she conducted a short stay 
 at the University of Oslo (UiO) with Res. Prof. David Balcells. Following 
 a postdoctoral period at UiO with Prof. Ainara Nova\, she was awarded a Ma
 rie Skłodowska-Curie Fellowship. Her current research focuses on the desi
 gn of bifunctional catalysts for CO₂ hydrogenation\, utilizing quantum m
 ethods and machine learning models.\n\nPaula Torren Peraire\nAligning Mach
 ine Learning Methods with Drug Discovery Objectives\nMachine learning is i
 ncreasingly shaping drug discovery\, with computational methods addressing
  challenges in molecular design\, synthesis planning\, and optimization. I
 n this talk\, I will present recent work on how computational choices infl
 uence discovery outcomes\, from retrosynthesis to generative chemistry. I 
 will first examine how different combinations of single-step and multi-ste
 p retrosynthesis models guide exploration of retrosynthetic space and can 
 enable convergent synthesis planning. I will then discuss de-novo molecula
 r design\, highlighting how multi objective optimization strategies shape 
 molecular exploration in many objective design settings. This talk undersc
 ores the importance of aligning algorithmic decisions with practical disco
 very objectives and explores opportunities for integrating data driven met
 hods into medicinal chemistry workflows\n\nBiography\nPaula Torren Peraire
  is a Data Science Innovation Fellow at Novartis in Basel\, where she work
 s on machine learning driven methods for drug discovery\, with a focus on 
 generative chemistry. She studied Pharmacy at the University of Barcelona\
 , followed by a Master’s in Bioinformatics for Health Sciences at Univer
 sitat Pompeu Fabra. Paula received her PhD from the Technical University o
 f Munich with a joint project between Helmholtz Munich and Johnson & Johns
 on\, focusing on computer-aided synthesis planning. Overall\, her work aim
 s to develop robust computational frameworks that support molecular design
  and decision-making in drug discovery\, bridging methodological innovatio
 n with real-world pharmaceutical applications.\n\n\n\n 
LOCATION:CH B3 30 https://plan.epfl.ch/?room==CH%20B3%2030
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR
